Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne A Phillips

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Molecular Cell|October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor SuppressionHon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Annals of Surgical Oncology|July 11, 2018
Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation SequencingKaren Chiam, George C Mayne, David I Watson, et al.
Clinical and Translational Medicine|May 13, 2022
Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damageJeffrey Molendijk, Cathryn M Kolka, Henry Cairns, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 11, 2020
Clinical pathways and outcomes of patients with Barrett's esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008-2016Renhua Na, Kyoko Miura, Suzanne O'Brien, et al.
Annals of Surgical Oncology|October 1, 2022
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal CancerCarlos S Cabalag, Owen W J Prall, John Ciciulla, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Barrett's esophagus: cancer and molecular biologyMichael K Gibson, Arashinder S Dhaliwal, Nicholas J Clemons, et al.
Cancer Discovery|March 28, 2018
Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant GrowthHelen B Pearson, Jason Li, Valerie S Meniel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancerSherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitorsKaren E Sheppard, Carleen Cullinane, Katherine M Hannan, et al.
The Journal of Clinical Investigation|January 5, 2012
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in miceKathryn M Kinross, Karen G Montgomery, Margarete Kleinschmidt, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Molecular Cell|October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor SuppressionHon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Annals of Surgical Oncology|July 11, 2018
Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation SequencingKaren Chiam, George C Mayne, David I Watson, et al.
Clinical and Translational Medicine|May 13, 2022
Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damageJeffrey Molendijk, Cathryn M Kolka, Henry Cairns, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 11, 2020
Clinical pathways and outcomes of patients with Barrett's esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008-2016Renhua Na, Kyoko Miura, Suzanne O'Brien, et al.
Annals of Surgical Oncology|October 1, 2022
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal CancerCarlos S Cabalag, Owen W J Prall, John Ciciulla, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Barrett's esophagus: cancer and molecular biologyMichael K Gibson, Arashinder S Dhaliwal, Nicholas J Clemons, et al.
Cancer Discovery|March 28, 2018
Identification of <i>Pik3ca</i> Mutation as a Genetic Driver of Prostate Cancer That Cooperates with <i>Pten</i> Loss to Accelerate Progression and Castration-Resistant GrowthHelen B Pearson, Jason Li, Valerie S Meniel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancerSherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitorsKaren E Sheppard, Carleen Cullinane, Katherine M Hannan, et al.
The Journal of Clinical Investigation|January 5, 2012
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in miceKathryn M Kinross, Karen G Montgomery, Margarete Kleinschmidt, et al.
Pageof 10